ARIH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.891000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.776200E-01
Normal-vs-Stage2
9.461000E-01
Normal-vs-Stage3
2.233200E-01
Normal-vs-Stage4
5.263000E-01
Stage1-vs-Stage2
9.445800E-01
Stage1-vs-Stage3
7.317700E-02
Stage1-vs-Stage4
3.256600E-01
Stage2-vs-Stage3
1.705630E-01
Stage2-vs-Stage4
3.363800E-01
Stage3-vs-Stage4
9.178100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.053600E-01
Normal-vs-AfricanAmerican
9.442000E-01
Normal-vs-Asian
5.624200E-01
Caucasian-vs-AfricanAmerican
7.806600E-01
Caucasian-vs-Asian
2.755000E-01
AfricanAmerican-vs-Asian
4.135400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.068000E-01
Normal-vs-Female
8.773600E-01
Male-vs-Female
9.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.742400E-01
Normal-vs-Age(41-60Yrs)
6.925600E-01
Normal-vs-Age(61-80Yrs)
7.029000E-01
Normal-vs-Age(81-100Yrs)
7.523400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.207600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.764800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.342800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.721800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.442230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.565200E-01
Normal-vs-Daily Drinker
5.558600E-01
Normal-vs-Weekly Drinker
5.925800E-01
Normal-vs-Occasional Drinker
8.638400E-01
Normal-vs-Social Drinker
9.776600E-01
Non Drinker-vs-Daily Drinker
6.537200E-01
Non Drinker-vs-Weekly Drinker
8.068000E-01
Non Drinker-vs-Occasional Drinker
2.222800E-01
Non Drinker-vs-Social Drinker
4.638600E-01
Daily Drinker-vs-Weekly Drinker
8.868400E-01
Daily Drinker-vs-Occasional Drinker
1.481390E-01
Daily Drinker-vs-Social Drinker
3.219200E-01
Weekly Drinker-vs-Occasional Drinker
2.290000E-01
Weekly Drinker-vs-Social Drinker
4.287800E-01
Occasional Drinker-vs-Social Drinker
7.342600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.277630E-01
Normal-vs-Grade 2
1.115600E-02
Normal-vs-Grade 3
1.777520E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.216300E-02
Grade 1-vs-Grade 3
2.206000E-02
Grade 1-vs-Grade 4
1.277630E-01
Grade 2-vs-Grade 3
3.246000E-01
Grade 2-vs-Grade 4
1.115600E-02
Grade 3-vs-Grade 4
1.777520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.644200E-01
Normal-vs-NonDiabetic
7.790000E-01
Diabetic-vs-NonDiabetic
6.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.471000E-01
Normal-vs-NoPancreatitis
7.733400E-01
Pancreatitis-vs-NoPancreatitis
3.830400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.417600E-01
Normal-vs-N1
9.957000E-01
N0-vs-N1
2.604800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.809000E-01
Normal-vs-TP53-NonMutant
6.732600E-01
TP53-Mutant-vs-TP53-NonMutant
5.862200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
